Gemini Pharmaceuticals Inc., has appointed Mark Gaeta as its Chief Operating Officer.
Mark has over 35 years’ experience in the pharmaceutical and dietary supplement industries, and previously held executive and senior leadership positions at large supplement and pharmaceutical (both ethical and generic) companies.
“We are very excited to have Mark as a member of our Gemini team,” said Mike Finamore, CEO of Gemini Pharmaceuticals. “His unsurpassed experience and success in our core businesses, as well as his familiarity with Gemini and our current organization, will be essential in helping us manage the next stages of our tremendous growth. Additionally, Mark will be a key driver of improvements to our quality and operational systems, allowing Gemini to expand its current product offerings and services to our diverse customer base both within the US and around the world.”